Latest On-Demand Webinars

The cannabis oil market is rapidly evolving across the globe. With legalization continuing throughout the world, producers are going to be faced with the daunting task of developing new products as consumer preferences change.

The development of new cannabis products is a very nuanced task. Not only do companies need to identify the right products to meet consumer’s needs, but the company also needs to identify the correct manufacturing equipment and processes to produce and replicate the desired product.

The balance between creating the right product and choosing the right manufacturing partners has allowed Cannacraft to differentiate itself from other companies in the cannabis market.

In this session, Cannacraft and Pall Corporation will share their experiences with new product development and how manufacturing equipment plays a role in the process.

Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation.

In this webinar, Dr. Kristin G. Anderson, Research Associate from the Greenberg lab at the Fred Hutchinson Cancer Research Center, discusses engineering T cells to improve survival in the immunosuppressive tumor microenvironment.

With the rapid increase in the development of oligonucleotide therapeutics and gene therapies, workflows for the identification, characterization and quantification of full-length products, their impurities and metabolites, are critical.

Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.

Join us for our extended webinar to hear about the most recent and innovative developments in the world of mass spectrometry and how they are helping to drive science forward.

Psychedelics have been used for millennia in both spiritual and medicinal contexts. Recently, a number of clinical successes with psychedelics have generated considerable excitement; nevertheless, mechanisms underlying their therapeutic efficacy are largely unknown.

In drug development, microphysiological systems (MPS) are utilized to develop in vitro biological models that can generate more physiologically- and human-relevant data.

Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.

This online symposium will highlight the latest advances in proteomics and metabolomics research and their applications in modern medicine.